Patents by Inventor Thomas O'Neill

Thomas O'Neill has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200148661
    Abstract: The present disclosure relates to salts of the compound: polymorphic forms thereof, methods for preparation and use thereof, and pharmaceutical compositions thereof.
    Type: Application
    Filed: June 18, 2019
    Publication date: May 14, 2020
    Applicant: Research Development Foundation
    Inventors: Michael O'NEILL, Barbara KIDON, Thomas ADKINS, Hongqiao WU, Emmanuel T. AKPORIAYE
  • Publication number: 20200130838
    Abstract: A system for providing a passenger interface for a passenger in a seat including at least one sensor adapted to generate a signal representative of the position, the configuration, and/or the direction of movement of hand of the passenger; a controller, and a projector for projecting a passenger interface, placement of which is determined based at least on the signal. A method includes receiving a first signal indicative of a position and/or an arm of the passenger; projecting, by a projector, a passenger interface onto a predetermined surface, the passenger interface location on the predetermined surface being based on the first signal, receiving a second signal indicative of the position, configuration, and/or direction of movement of the passenger's hand of with respect to the passenger interface; and adjusting at least one of a passenger controllable feature, and projection of at least one media display by a second projector.
    Type: Application
    Filed: October 28, 2019
    Publication date: April 30, 2020
    Inventors: Nikolas BEAUDIN, Seung Joon BANG, Louis GAGNON-SEGUIN, Thomas FINKHELSTEIN, Omar MASAUD, Mojtaba AHMADI, Darren O'NEILL, Chantal Marie-Josee TRUDEL
  • Patent number: 10621147
    Abstract: Embodiments are directed to a file system engine that provides a file system with parent objects associated with child objects. The file system engine provides a replication snapshot associated with an epoch of the file system such that each child object modified during the epoch and each associated parent object is associated with the replication snapshot. A root object of a portion of the file system included in the replication snapshot may be provided. A replication engine may traverse the portion of file system starting from the root object such that the parent objects that are not associated with the replication snapshot are omitted from the traversal. The replication engine may determine replication objects based on the traversal such that each replication object was modified during the epoch. Then the replication engine may execute a replication job that copies replication objects to a target file system.
    Type: Grant
    Filed: December 19, 2018
    Date of Patent: April 14, 2020
    Assignee: Qumulo, Inc.
    Inventors: Junjie Liang, Neal Thomas Fachan, Kevin David Jamieson, Kevin Ross O'Neill, Michael Anthony Chmiel
  • Patent number: 10606812
    Abstract: Embodiments are directed to file systems. A replication engine may establish a secure communication channel between a source file system and a target file system. The replication engine may: instantiate a replication job associated with rules; determine changes in the source file system; determine characteristics of the replication job that may be based on the changes; compare the to the characteristics and a black-out schedule; execute the replication job to communicate the changes in the source file system to the target file system based on a result of the comparison. Upon completion of the replication job, the replication engine may automatically instantiating a next replication job to copy subsequent changes in the source file system to the target file system.
    Type: Grant
    Filed: September 7, 2018
    Date of Patent: March 31, 2020
    Assignee: Qumulo, Inc.
    Inventors: Ezra Elias Kilty Cooper, Neal Thomas Fachan, Junjie Liang, Kevin Ross O'Neill, Michael Anthony Chmiel
  • Patent number: 10568755
    Abstract: A gastrointestinal device and method for retrieving the device are disclosed. The device may include a stent including a plurality of strands forming first and second ends, the strands configured to move between a retrieval configuration, with substantially parallel strands, and a deployed configuration, wherein the strands form proximal and distal portions having first and second diameters larger than the pyloric sphincter. The device may include a connector assembly including proximal, middle, and distal connectors. The middle connector may be coupled to the proximal and distal connectors when the strands are in the deployed configuration. The strands may be attached to the proximal and distal connectors and the first and second ends. The device may include a release mechanism configured to decouple the proximal connector from the middle connector. Decoupling of the proximal and middle connectors may allow the strands to move from the deployed to retrieval configuration.
    Type: Grant
    Filed: July 10, 2017
    Date of Patent: February 25, 2020
    Assignee: LEAN MEDICAL TECHNOLOGIES, INC.
    Inventors: William Gerald O'Neill, Richard Merrell Chesbrough, Naresh Thomas Gunaratnam, Vishal J. Bhagat, Christopher John Gostout
  • Publication number: 20190375480
    Abstract: An electronic throttle control assembly for a vehicle has a housing that mounts to a handlebar of the vehicle and defines an interior. A rack gear is mounted in the interior for movement in a linear, translational, and/or radial direction. A pinion gear within the interior moves the rack gear upon rotation of the pinion gear. A sensor target is coupled to the rack gear. A sensor detects a position of the sensor target and generates an electric signal for a vehicle control unit. A grip is coupled to the pinion gear, rotation of the grip moving the rack gear and sensor target in a linear, translational, and/or radial direction, the electric signal varying based on the change in position of the sensor target. Opposing springs within the housing resist movement of the rack gear and rest in a normally preloaded state.
    Type: Application
    Filed: June 6, 2018
    Publication date: December 12, 2019
    Applicant: Sensata Technologies, Inc.
    Inventors: Mark Allen Pankratz, Edmund Charles O'Neill, Joshua Gayle Boltz, Paul Robert Erickson, Andrew Reid Daavettila, Jeremiah Thomas Rau, Gerald Scherbing
  • Publication number: 20190332579
    Abstract: Embodiments are directed to file systems. A replication engine may establish a secure communication channel between a source file system and a target file system. The replication engine may: instantiate a replication job associated with rules; determine changes in the source file system; determine characteristics of the replication job that may be based on the changes; compare the to the characteristics and a black-out schedule; execute the replication job to communicate the changes in the source file system to the target file system based on a result of the comparison. Upon completion of the replication job, the replication engine may automatically instantiating a next replication job to copy subsequent changes in the source file system to the target file system.
    Type: Application
    Filed: September 7, 2018
    Publication date: October 31, 2019
    Inventors: Ezra Elias Kilty Cooper, Neal Thomas Fachan, Junjie Liang, Kevin Ross O'Neill
  • Patent number: 10459892
    Abstract: A software and hardware facility persistently maintains metrics on directories at different levels within a tree of a filesystem. The facility hierarchically aggregates attributes of files contained by directories and stores them as metric values in each directory within a tree. The stored values represent summed or otherwise aggregated data from the descendant directories and files. The metric values represent aggregated attributes such as total space consumed by a directory and all the descendant directories and files, total number of files within a directory, total data blocks used by a directory and its descendant directories and data files, etc.
    Type: Grant
    Filed: January 12, 2015
    Date of Patent: October 29, 2019
    Assignee: Qumulo, Inc.
    Inventors: Peter Godman, Kevin O'Neill, Thomas Urban, Justin Husted, Graeme Williams
  • Publication number: 20190259546
    Abstract: The present application is directed to compositions and methods of preparing carbon materials. The carbon materials prepared according to compositions and methods described herein comprise enhanced electrochemical properties and find utility in any number of electrical devices, for example, as electrode material in ultracapacitors.
    Type: Application
    Filed: January 24, 2019
    Publication date: August 22, 2019
    Inventors: Benjamin Kron, Aaron Feaver, William O'Neill, Robert Herrick, Heather Widgren, Thomas Arandt
  • Publication number: 20190252070
    Abstract: A medical device (10) for use in a Magnetic Resonance environment includes a keypad (22) having keys (24). Light sources (26) are disposed with respective keys of the keypad to illuminate the respective keys. At least one electronic processor (18) is programmed to: perform user interfacing operations in which user inputs are received via the keypad; during the user interfacing operations, control the light sources to selectively illuminate keys usable in the user interfacing operations; and controlling or configuring the medical device in accord with the user inputs received during the user interfacing operations.
    Type: Application
    Filed: September 29, 2017
    Publication date: August 15, 2019
    Applicant: KONINKLIJKE PHILIPS N.V.
    Inventors: Mark Shih-Chieh LIN, Donald Alan FORRER JR, Ronald Paul CONSIGLIO, John Thomas JUDY, Francis Patrick O'NEILL
  • Patent number: 10370350
    Abstract: The present disclosure relates to salts of the compound (I), polymorphic forms thereof, methods for preparation and use thereof, and pharmaceutical compositions thereof.
    Type: Grant
    Filed: September 5, 2014
    Date of Patent: August 6, 2019
    Assignee: Research Development Foundation
    Inventors: Michael O'Neill, Barbara Kidon, Thomas Adkins, Hongqiao Wu, Emmanuel T. Akporiaye
  • Publication number: 20190216905
    Abstract: Formulations comprising recombinant human tripeptidyl peptidase-1 (rhTPP1) for intrathecal, intracerebroventricular, or intraocular administration, and kits comprising the same, are disclosed. Methods of using rhTPP1 in the prevention and treatment of symptoms of Neuronal Ceroid Lipofuscinosis (CLN2) disease are also disclosed. The formulations and methods are effective in halting the progression of CLN2 disease and may be used to treat subjects having CLN2 or a family history of CLN2.
    Type: Application
    Filed: March 28, 2019
    Publication date: July 18, 2019
    Inventors: Thomas Lester, Saeed Moshashaee, Augustus O. Okhamafe, Charles A. O'Neill
  • Patent number: 10253042
    Abstract: The present invention is directed to compounds, tautomers and pharmaceutically acceptable salts of the compounds which are disclosed, wherein the compounds have the structure of Formula I, wherein the variables R1, R2, R3, R4 and X are as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.
    Type: Grant
    Filed: August 16, 2017
    Date of Patent: April 9, 2019
    Assignee: Pfizer Inc.
    Inventors: Michael Aaron Brodney, Christopher Ryan Butler, Lei Zhang, Brian Thomas O'Neill
  • Patent number: 10112958
    Abstract: The present invention is directed to compounds, tautomers and pharmaceutically acceptable salts of the compounds which are disclosed, wherein the compounds have the structure of Formula I, and the variables R1, R2 and R3 are as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.
    Type: Grant
    Filed: July 11, 2017
    Date of Patent: October 30, 2018
    Assignee: Pfizer Inc.
    Inventors: Michael Aaron Brodney, Christopher Ryan Butler, Lei Zhang, Brian Thomas O'Neill, Patrick Robert Verhoest, Peter Justin Mikochik, John Charles Murray, Xinjun Hou
  • Patent number: 10028962
    Abstract: The present invention is directed to compounds, tautomers and pharmaceutically acceptable salts of the compounds which are disclosed, wherein the compounds have the structure of Formula I, and the variable R1 is as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.
    Type: Grant
    Filed: June 21, 2017
    Date of Patent: July 24, 2018
    Assignee: Pfizer Inc.
    Inventors: Michael Aaron Brodney, Elizabeth Mary Beck, Christopher Ryan Butler, Lei Zhang, Brian Thomas O'Neill, Gabriela Barreiro, Erik Alphie LaChapelle, Bruce Nelsen Rogers
  • Publication number: 20170369506
    Abstract: The present invention is directed to compounds, tautomers and pharmaceutically acceptable salts of the compounds which are disclosed, wherein the compounds have the structure of Formula I, wherein the variables R1, R2, R3, R4 and X are as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.
    Type: Application
    Filed: August 16, 2017
    Publication date: December 28, 2017
    Applicant: Pfizer Inc.
    Inventors: Michael Aaron Brodney, Christopher Ryan Butler, Lei Zhang, Brian Thomas O'Neill
  • Publication number: 20170305931
    Abstract: The present invention is directed to compounds, tautomers and pharmaceutically acceptable salts of the compounds which are disclosed, wherein the compounds have the structure of Formula I, and the variables R1, R2 and R3 are as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.
    Type: Application
    Filed: July 11, 2017
    Publication date: October 26, 2017
    Applicant: Pfizer Inc.
    Inventors: Michael Aaron Brodney, Christopher Ryan Butler, Lei Zhang, Brian Thomas O'Neill, Patrick Robert Verhoest, Peter Justin Mikochik, John Charles Murray, Xinjun Hou
  • Publication number: 20170304312
    Abstract: The present invention is directed to compounds, tautomers and pharmaceutically acceptable salts of the compounds which are disclosed, wherein the compounds have the structure of Formula I, and the variable R1 is as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.
    Type: Application
    Filed: June 21, 2017
    Publication date: October 26, 2017
    Applicant: Pfizer Inc.
    Inventors: Michael Aaron Brodney, Elizabeth Mary Beck, Christopher Ryan Butler, Lei Zhang, Brian Thomas O'Neill, Gabriela Barreiro, Erik Alphie LaChapelle, Bruce Nelsen Rogers
  • Patent number: 9771379
    Abstract: The present invention is directed to compounds, tautomers and pharmaceutically acceptable salts of the compounds which are disclosed, wherein the compounds have the structure of Formula I, wherein the variables R1, R2, R3, R4 and X are as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.
    Type: Grant
    Filed: September 22, 2016
    Date of Patent: September 26, 2017
    Assignee: PFIZER INC.
    Inventors: Michael Aaron Brodney, Christopher Ryan Butler, Lei Zhang, Brian Thomas O'Neill
  • Patent number: 9751895
    Abstract: The present invention is directed to compounds, tautomers and pharmaceutically acceptable salts of the compounds which are disclosed, wherein the compounds have the structure of Formula I, and the variables R1, R2 and R3 are as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.
    Type: Grant
    Filed: September 22, 2016
    Date of Patent: September 5, 2017
    Assignee: Pfizer Inc.
    Inventors: Michael Aaron Brodney, Christopher Ryan Butler, Lei Zhang, Brian Thomas O'Neill, Patrick Robert Verhoest, Peter Justin Mikochik, John Charles Murray, Xinjun Hou